
0.6475 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 0.39 Today|||52-Week Range 1.01 | +24.33% Year-to-Date |
Lannett (LCI) Reports Q2 Loss, Tops Revenue Estimates Feb 01 / Zacks.com - Paid Partner Content |
Previous close | 0.65 |
Today’s open | 0.68 |
Day’s range | 0.60 - 0.68 |
Volume | 210,868 |
Average volume (3 months) | 228,589 |
Market cap | $28.5M |
Earnings growth (last year) | +37.79% |
Earnings growth (this year) | -2.98% |
Earnings growth (next 5 years) | -3.60% |
Revenue growth (last year) | -28.86% |
P/E ratio | NM |
Price/Sales | 0.07 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
LUMOLumos Pharma Inc | -0.05 | -1.44% |
---- | ||
ZYNEZynerba Pharmaceutic... | -0.02 | -3.21% |
CYCNCyclerion Therapeuti... | 0.00 | 0.00% |
Next reporting date | May 3, 2023 |
EPS forecast (this quarter) | -$0.39 |
Annual revenue (last year) | $340.6M |
Annual profit (last year) | -$231.6M |
Net profit margin | -68.01% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Trevose, Pennsylvania |